149 related articles for article (PubMed ID: 12063245)
1. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity.
Vega RB; Yang J; Rothermel BA; Bassel-Duby R; Williams RS
J Biol Chem; 2002 Aug; 277(33):30401-7. PubMed ID: 12063245
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1.
Abbasi S; Lee JD; Su B; Chen X; Alcon JL; Yang J; Kellems RE; Xia Y
J Biol Chem; 2006 Mar; 281(12):7717-26. PubMed ID: 16415348
[TBL] [Abstract][Full Text] [Related]
3. Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo.
Sanna B; Brandt EB; Kaiser RA; Pfluger P; Witt SA; Kimball TR; van Rooij E; De Windt LJ; Rothenberg ME; Tschop MH; Benoit SC; Molkentin JD
Proc Natl Acad Sci U S A; 2006 May; 103(19):7327-32. PubMed ID: 16648267
[TBL] [Abstract][Full Text] [Related]
4. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.
Vega RB; Rothermel BA; Weinheimer CJ; Kovacs A; Naseem RH; Bassel-Duby R; Williams RS; Olson EN
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):669-74. PubMed ID: 12515860
[TBL] [Abstract][Full Text] [Related]
5. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling.
Rothermel B; Vega RB; Yang J; Wu H; Bassel-Duby R; Williams RS
J Biol Chem; 2000 Mar; 275(12):8719-25. PubMed ID: 10722714
[TBL] [Abstract][Full Text] [Related]
6. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1.
Pedram A; Razandi M; Aitkenhead M; Levin ER
J Biol Chem; 2005 Jul; 280(28):26339-48. PubMed ID: 15899894
[TBL] [Abstract][Full Text] [Related]
7. The role of modulatory calcineurin-interacting proteins in calcineurin signaling.
Rothermel BA; Vega RB; Williams RS
Trends Cardiovasc Med; 2003 Jan; 13(1):15-21. PubMed ID: 12554096
[TBL] [Abstract][Full Text] [Related]
8. The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation.
Abbasi S; Su B; Kellems RE; Yang J; Xia Y
J Biol Chem; 2005 Nov; 280(44):36737-46. PubMed ID: 16126726
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
[TBL] [Abstract][Full Text] [Related]
10. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway.
Bush E; Fielitz J; Melvin L; Martinez-Arnold M; McKinsey TA; Plichta R; Olson EN
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2870-5. PubMed ID: 14976250
[TBL] [Abstract][Full Text] [Related]
11. Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein.
Lin HY; Michtalik HJ; Zhang S; Andersen TT; Van Riper DA; Davies KK; Ermak G; Petti LM; Nachod S; Narayan AV; Bhatt N; Crawford DR
Free Radic Biol Med; 2003 Sep; 35(5):528-39. PubMed ID: 12927602
[TBL] [Abstract][Full Text] [Related]
12. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
[TBL] [Abstract][Full Text] [Related]
13. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles.
Yang J; Rothermel B; Vega RB; Frey N; McKinsey TA; Olson EN; Bassel-Duby R; Williams RS
Circ Res; 2000 Dec; 87(12):E61-8. PubMed ID: 11110780
[TBL] [Abstract][Full Text] [Related]
14. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.
Rothermel BA; McKinsey TA; Vega RB; Nicol RL; Mammen P; Yang J; Antos CL; Shelton JM; Bassel-Duby R; Olson EN; Williams RS
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3328-33. PubMed ID: 11248078
[TBL] [Abstract][Full Text] [Related]
15. System-level investigation into the regulatory mechanism of the calcineurin/NFAT signaling pathway.
Shin SY; Yang JM; Choo SM; Kwon KS; Cho KH
Cell Signal; 2008 Jun; 20(6):1117-24. PubMed ID: 18325738
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function.
Hill JA; Rothermel B; Yoo KD; Cabuay B; Demetroulis E; Weiss RM; Kutschke W; Bassel-Duby R; Williams RS
J Biol Chem; 2002 Mar; 277(12):10251-5. PubMed ID: 11786544
[TBL] [Abstract][Full Text] [Related]
17. Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in yeast.
Mehta S; Li H; Hogan PG; Cunningham KW
Mol Cell Biol; 2009 May; 29(10):2777-93. PubMed ID: 19273587
[TBL] [Abstract][Full Text] [Related]
18. A conserved family of calcineurin regulators.
Kingsbury TJ; Cunningham KW
Genes Dev; 2000 Jul; 14(13):1595-604. PubMed ID: 10887154
[TBL] [Abstract][Full Text] [Related]
19. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
20. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.
Chan B; Greenan G; McKeon F; Ellenberger T
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13075-80. PubMed ID: 16131541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
